Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Other Non-Current Liabilities: 2015-2025

Historic Other Non-Current Liabilities for Mesoblast (MESO) over the last 8 years, with Jun 2025 value amounting to $10.8 million.

  • Mesoblast's Other Non-Current Liabilities rose 1.63% to $10.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $10.8 million, marking a year-over-year increase of 1.63%. This contributed to the annual value of $10.8 million for FY2025, which is 1.63% up from last year.
  • Latest data reveals that Mesoblast reported Other Non-Current Liabilities of $10.8 million as of Q2 2025, which was down 60.85% from $27.6 million recorded in Q4 2024.
  • Mesoblast's Other Non-Current Liabilities' 5-year high stood at $27.6 million during Q4 2024, with a 5-year trough of $2.2 million in Q2 2022.
  • Its 3-year average for Other Non-Current Liabilities is $14.8 million, with a median of $13.9 million in 2023.
  • As far as peak fluctuations go, Mesoblast's Other Non-Current Liabilities tumbled by 33.27% in 2021, and later surged by 148.33% in 2023.
  • Mesoblast's Other Non-Current Liabilities (Quarterly) stood at $22.3 million in 2021, then fell by 19.90% to $17.9 million in 2022, then dropped by 4.37% to $17.1 million in 2023, then skyrocketed by 61.47% to $27.6 million in 2024, then rose by 1.63% to $10.8 million in 2025.
  • Its last three reported values are $10.8 million in Q2 2025, $27.6 million for Q4 2024, and $10.6 million during Q2 2024.